Nanomedicine News

RSS

Dicerna's Lipid Nanoparticle Therapy for Primary Hyperoxaluria Type 1 Granted EMA Orphan Drug Designation

Dicerna Pharmaceuticals, Inc., a leading developer of RNA interference (RNAi) therapeutics, today announced that the European Medicines Agency (EMA) granted Orphan Drug Designation to DCR-PH1, the company's therapeutic candidate for the treatment of primary hyperoxaluria type 1 (PH1). PH1 is a severe, rare, inherited disorder of the liver that often results in kidney failure and for which there are no approved therapies.

10 Aug 2015

Nanofabrication Techniques Could Help Develop Brain-Friendly Interfaces

Recent research published in the journal Microsystems & Nanoengineering could eventually change the way people living with prosthetics and spinal cord injury lead their lives.

10 Aug 2015

Oasmia Reports Topline Findings from Paclical- Abraxane Head-to-Head Comparison Study for Metastatic Breast Cancer

Oasmia Pharmaceutical AB, a developer of a new generation of drugs within human and veterinary oncology, announced today the topline findings from a head-to-head comparison study of its lead human cancer product Paclical® and Celgene’s Abraxane®, which show similar pharmacokinetic (PK) profiles. The study was conducted in women with metastatic breast cancer.

5 Aug 2015

New Method to Switch Polarization of Nanomagnets Could Enable High-Density Storage on Integrated Circuits

UC Berkeley researchers have discovered a new way to switch the polarization of nanomagnets, paving the way for high-density storage to move from hard disks onto integrated circuits.

5 Aug 2015

Packaging Cancer Drug into Nanoparticles Double’s Tumor Destroying Efficacy

Researchers have packaged a widely used cancer drug into nanoparticles, more than doubling its effectiveness at destroying tumors.

5 Aug 2015

Integrated Microfluidic Chip Design with Embedded 3D Hydrogel Scaffold Can Help Capture Circulating Tumor Cells

A team of researchers from Massachusetts General Hospital, Florida State University, and University of Massachusetts has developed a new design of microchip that can retrieve microfluidically attached cancer cells for serial in vitro or in vivo analysis by via integrating a 3D hydrogel scaffold into a fluidic device. The researchers describe their approach in the forthcoming issue of the journal TECHNOLOGY.

5 Aug 2015

Nanoluminous Crystals Hold Promise for Development of New Bioimaging Technologies

Researchers at UMass Medical School (UMMS) have successfully developed light-emitting nanocrystals that could help advance non-invasive bioimaging technologies. These nanocrystals would enable utilization of persistent luminescence nanoparticles for bioimaging applications in the clinic, and in research laboratories. This would allow functional and structural biological processes in patients and in living animals to be evaluated.

4 Aug 2015

Study Shows Vaccine with Virus-Like Nanoparticles Can Effectively Treat RSV

A vaccine containing virus-like nanoparticles, or microscopic, genetically engineered particles, is an effective treatment for respiratory syncytial virus (RSV), according to researchers at Georgia State University.

4 Aug 2015

Researchers Design DNA-Loaded Nanoparticles for Breaching Mucus Barrier in Lungs

Nanotechnology could one day provide an inhaled vehicle to deliver targeted therapeutic genes for those suffering from life-threatening lung disorders. Researchers may have discovered first gene delivery system that efficiently penetrates the hard-to-breach human airway mucus barrier of lung tissue.

4 Aug 2015

Diamond Nanocrystals Act as Temperature Sensors for Hyperlocalised Cancer Therapy

Precise targeting biological molecules, such as cancer cells, for treatment is a challenge, due to their sheer size. Now ,Taiwanese scientists have proposed an advanced solution, based on a novel combination of previously used techniques, which can potentially be applied to thermal cancer therapy.

3 Aug 2015

Nanomedicine News

Dicerna's Lipid Nanoparticle Therapy for Primary Hyperoxaluria Type 1 Granted EMA Orphan Drug Designation

Nanofabrication Techniques Could Help Develop Brain-Friendly Interfaces

Oasmia Reports Topline Findings from Paclical- Abraxane Head-to-Head Comparison Study for Metastatic Breast Cancer

New Method to Switch Polarization of Nanomagnets Could Enable High-Density Storage on Integrated Circuits

Packaging Cancer Drug into Nanoparticles Double’s Tumor Destroying Efficacy

Integrated Microfluidic Chip Design with Embedded 3D Hydrogel Scaffold Can Help Capture Circulating Tumor Cells

Nanoluminous Crystals Hold Promise for Development of New Bioimaging Technologies

Study Shows Vaccine with Virus-Like Nanoparticles Can Effectively Treat RSV

Researchers Design DNA-Loaded Nanoparticles for Breaching Mucus Barrier in Lungs

Diamond Nanocrystals Act as Temperature Sensors for Hyperlocalised Cancer Therapy

Enhanced Antibacterial Polylactic Acid-Curcumin Nanofibers for Wound Dressings

Gold Nanoparticles to Restore Vision in Retinal Disorders

Levidian and Zentek Seek to Establish Graphene-Integrated Filter Manufacturing Facility in the Middle East to Advance Cleaner, Safer Air

Scalable Method for Porous Graphene Membranes for CO2 Capture

Biochar-Modified Titanium Dioxide Nanocomposites for Enhanced Water Treatment

Overcoming Nanogold Production Challenges

Electrospinning and the Future of Nanotechnology

How Electrospinning is Shaping the Future of Nanotechnology

Sponsored Content

Utilizing Back-Gate Voltage Biases for 2D Materials

Resistivity Metrology for Sputtered ITO Thin Films

How Plasma Cleaning Technology Tackles Hydrocarbon Contamination

Optimizing EV Lubricants with Electrified Tribotesting